PeptideTrace
Clinical

New clinical trial registered for Semaglutide

Related compound: SemaglutideView source →

MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial (NCT07505303) registered on ClinicalTrials.gov. Phase: phase 2. Status: not yet recruiting.